(Q28307216)

2

0 references

Changping Li

3

0 references

Jesus Gomez-Navarro

4

0 references

Viviana A Bozon

5

0 references

Charla A Parker

6

0 references

Ingrid M Hernandez

7

0 references

Carolina Gutierrez

8

0 references

Gabriel Lopez-Berestein

9

0 references

Luis H Camacho

High frequency of antitumor T cells in the blood of melanoma patients before and after vaccination with tumor antigens

10

0 references

language of work or name

English

0 references

publication date

1 June 2006

0 references

published in

Cancer

0 references

volume

106

0 references

issue

11

0 references

page(s)

2437-44

0 references

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21854

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21854

CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21854

Regulatory T cells selectively express toll-like receptors and are activated by lipopolysaccharide

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21854

Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25(+)CD4(+) regulatory cells that control intestinal inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21854

B7/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21854

CTLA-4 engagement inhibits IL-2 accumulation and cell cycle progression upon activation of resting T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21854

Type 1 T regulatory cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21854

PD-1 ligands, negative regulators for activation of naive, memory, and recently activated human CD4+ T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21854

CTLA-4 and PD-1 receptors inhibit T-cell activation by distinct mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21854

Manipulation of T cell costimulatory and inhibitory signals for immunotherapy of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21854

Elimination of residual metastatic prostate cancer after surgery and adjunctive cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) blockade immunotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21854

Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21854

Autoimmunity in a phase I trial of a fully human anti-cytotoxic T-lymphocyte antigen-4 monoclonal antibody with multiple melanoma peptides and Montanide ISA 51 for patients with resected stages III and IV melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21854

Ex vivo isolation and characterization of CD4(+)CD25(+) T cells with regulatory properties from human blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21854

Foxp3: a critical regulator of the development and function of regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21854

Antitumor activity in melanoma and anti-self responses in a phase I trial with the anti-cytotoxic T lymphocyte-associated antigen 4 monoclonal antibody CP-675,206.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21854

Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21854

Foxp3 and natural regulatory T cells: key to a cell lineage?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21854

Stimulation of CD25(+)CD4(+) regulatory T cells through GITR breaks immunological self-tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21854

Treatment of advanced tumors with agonistic anti-GITR mAb and its effects on tumor-infiltrating Foxp3+CD25+CD4+ regulatory T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21854

CTLA-4-mediated inhibition in regulation of T cell responses: mechanisms and manipulation in tumor immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21854

Regulation of murine chronic colitis by CD4+CD25- programmed death-1+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21854

Strategies for immunotherapy of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21854

7 January 2021

CD4+CD25high regulatory cells in human peripheral blood

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21854

7 January 2021

Suppressor effector function of CD4+CD25+ immunoregulatory T cells is antigen nonspecific

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21854

7 January 2021

Cutting edge: control of CD8+ T cell activation by CD4+CD25+ immunoregulatory cells

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21854

7 January 2021

Role for IL-10 in suppression mediated by peptide-induced regulatory T cells in vivo

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21854

7 January 2021

Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21854

7 January 2021

Blockade of programmed death-1 ligands on dendritic cells enhances T cell activation and cytokine production

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21854

7 January 2021

Costimulation via glucocorticoid-induced TNF receptor in both conventional and CD25+ regulatory CD4+ T cells

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21854

7 January 2021

Engagement of glucocorticoid-induced TNFR family-related receptor on effector T cells by its ligand mediates resistance to suppression by CD4+CD25+ T cells.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21854

7 January 2021

Reporting results of cancer treatment

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21854

7 January 2021

Toxicity and response criteria of the Eastern Cooperative Oncology Group

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21854

7 January 2021

Analysis of FOXP3 protein expression in human CD4+CD25+ regulatory T cells at the single-cell level

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21854

7 January 2021

SHP-1 and SHP-2 associate with immunoreceptor tyrosine-based switch motif of programmed death 1 upon primary human T cell stimulation, but only receptor ligation prevents T cell activation

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21854

7 January 2021

Foxp3 expressing CD4+CD25(high) regulatory T cells are overrepresented in human metastatic melanoma lymph nodes and inhibit the function of infiltrating T cells

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21854

7 January 2021